(R)-(-)-2-Methoxypropanol synthesis
- Product Name:(R)-(-)-2-Methoxypropanol
- CAS Number:6131-59-5
- Molecular formula:C4H10O2
- Molecular Weight:90.12
23943-96-6
77 suppliers
$52.00/100mg
6131-59-5
39 suppliers
$503.87/5MG
Yield: 100%
Reaction Conditions:
with dimethylsulfide borane complex in dichloromethane at 0 - 20;Inert atmosphere;
Steps:
29.1A (2R)-2-Methoxypropan-1-ol
[1239] Under argon and at oo C., 858 fll (8.39 mmol, 1.8eq.) ofborane/dimethyl sulphide complex were added dropwiseto a solution of 500 mg ( 4.66 mmol) of (R)-( + )-2-methoxypropionic acid in 10 ml of dichloromethane, thereaction mixture was stirred at RT overnight and aqueoussodium hydroxide solution (2M) was then added dropwise.After phase separation, the aqueous phase was extracted withdichloromethane. The combined organic phases were dried(sodium sulphate), filtered, concentrated under reduced pressure(water bath 300 mbar) and dried.Yield: 490 mg (quant.)[1240] 1H-NMR (400 MHz, DMSO-d6): o [ppm]=4.55 (t,lH), 3.40-3.31 (m, lH), 3.30-3.20 (m, 2H), 3.24 (s, 3H), 1.02(d, 3H).
References:
BAYER PHARMA AKTIENGESELLSCHAFT;R?HRIG, Susanne;HILLISCH, Alexander;STRA?BURGER, Julia;HEITMEIER, Stefan;SCHMIDT, Martina Victoria;SCHLEMMER, Karl-Heinz;TERSTEEGEN, Adrian;BUCHMüLLER, Anja;GERDES, Christoph;SCH?FER, Martina;KINZEL, Tom;TELLER, Henrik;SCHIROK, Hartmut;KLAR, Jürgen;NUNEZ, Eloisa JIMENEZ US2016/52884, 2016, A1 Location in patent:Paragraph 1238-1240
40105-20-2
22 suppliers
$339.00/1g
6131-59-5
39 suppliers
$503.87/5MG
67-56-1
751 suppliers
$7.29/5ml-f
16088-62-3
201 suppliers
$21.00/1mL
4984-22-9
158 suppliers
$8.00/1g
6131-59-5
39 suppliers
$503.87/5MG
19141-39-0
87 suppliers
$14.00/250mg
4324-39-4
11 suppliers
inquiry
116422-39-0
71 suppliers
$739.77/1G
6131-59-5
39 suppliers
$503.87/5MG
67-56-1
751 suppliers
$7.29/5ml-f
15448-47-2
192 suppliers
$50.00/1g
26550-55-0
130 suppliers
$8.00/1g
4984-22-9
158 suppliers
$8.00/1g
116422-39-0
71 suppliers
$739.77/1G
6131-59-5
39 suppliers
$503.87/5MG
1000210-73-0
0 suppliers
inquiry
76946-22-0
0 suppliers
inquiry